Related references
Note: Only part of the references are listed.Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer
Zaoqu Liu et al.
NATURE COMMUNICATIONS (2022)
A Pan-Cancer Analysis of the Oncogenic Role of Cell Division Cycle-Associated Protein 4 (CDCA4) in Human Tumors
Hui Fang et al.
FRONTIERS IN IMMUNOLOGY (2022)
Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer
Zaoqu Liu et al.
EBIOMEDICINE (2022)
Multi-omics analysis of intra-tumoural and inter-tumoural heterogeneity in pancreatic ductal adenocarcinoma
Xiaoqian Liu et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2022)
Multi-omics landscape and clinical significance of a SMAD4-driven immune signature: Implications for risk stratification and frontline therapies in pancreatic cancer
Libo Wang et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)
PRR11 induces filopodia formation and promotes cell motility via recruiting ARP2/3 complex in non-small cell lung cancer cells
Zhili Wei et al.
GENES & DISEASES (2022)
Prognosis and personalized treatment prediction in TP53-mutant hepatocellular carcinoma: an in silico strategy towards precision oncology
Chen Yang et al.
BRIEFINGS IN BIOINFORMATICS (2021)
The Irradiated Brain Microenvironment Supports Glioma Stemness and Survival via Astrocyte-Derived Transglutaminase 2
Tracy J. Berg et al.
CANCER RESEARCH (2021)
Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer
William M. Grady et al.
GASTROENTEROLOGY (2021)
Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management
Zaoqu Liu et al.
JOURNAL OF ONCOLOGY (2021)
The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma
Zaoqu Liu et al.
FRONTIERS IN ONCOLOGY (2021)
Treatment landscape of metastatic pancreatic cancer
Sara De Dosso et al.
CANCER TREATMENT REVIEWS (2021)
Multi-omics consensus ensemble refines the classification of muscle-invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies
Xiaofan Lu et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer
Aesha Ali et al.
CLINICAL CANCER RESEARCH (2021)
Pancreatic Cancer: A Review
Wungki Park et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53
Patrizia Malkomes et al.
ONCOGENE (2021)
Clinical Significance and Inflammatory Landscape of a Novel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer
Zaoqu Liu et al.
FRONTIERS IN IMMUNOLOGY (2021)
PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability
Siming Chen et al.
JCI INSIGHT (2021)
Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma
Qihang Yuan et al.
BIOENGINEERED (2021)
Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation
Max M. Wattenberg et al.
BRITISH JOURNAL OF CANCER (2020)
Predicted Prognosis of Patients with Pancreatic Cancer by Machine Learning
Seiya Yokoyama et al.
CLINICAL CANCER RESEARCH (2020)
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials
Robert C. Doebele et al.
LANCET ONCOLOGY (2020)
Amplification of transglutaminase 2 enhances tumor-promoting inflammation in gastric cancers
Sung-Yup Cho et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma
Chaoqi Zhang et al.
CANCER LETTERS (2020)
Challenges and Opportunities for Pancreatic Cancer Immunotherapy
Adham S. Bear et al.
CANCER CELL (2020)
Treatment after progression in the era of immunotherapy
Salem Billan et al.
LANCET ONCOLOGY (2020)
The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis prediction
Zhen Tan et al.
Aging-US (2020)
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study
Mark H O'Hara et al.
LANCET ONCOLOGY (2020)
Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors
Dan Sha et al.
CANCER DISCOVERY (2020)
Proline rich 11 (PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancer
Kyung-min Lee et al.
NATURE COMMUNICATIONS (2020)
The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells
Mengjia He et al.
ONCOGENE (2019)
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Talia Golan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer
Shigeru Hashimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
MiR-532-3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/β-catenin signaling
Chuncai Gu et al.
CELL DEATH & DISEASE (2019)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Tathiane M. Malta et al.
CELL (2018)
Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer
Chunling Hu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Somatic copy number alterations have prognostic impact in patients with ovarian clear cell carcinoma
Asuka Morikawa et al.
ONCOLOGY REPORTS (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Silencing of PRR11 suppresses cell proliferation and induces autophagy in NSCLC cells
Lian Zhang et al.
GENES & DISEASES (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Activating CYSLTR2 and PLCB4 Mutations in Primary Leptomeningeal Melanocytic Tumors
Johannes A. P. van de Nes et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Aravind Subramanian et al.
CELL (2017)
The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma
Vandana Sandhu et al.
CANCER RESEARCH (2016)
An interstitial deletion within 9p21.3 and extending beyond CDKN2A predisposes to melanoma, neural system tumours and possible haematological malignancies
Maria J. Baker et al.
JOURNAL OF MEDICAL GENETICS (2016)
AREG and EREG as Predictive Biomarkers for RAS Wild-Type Colorectal Cancer Treated With Panitumumab A Fresh Approach to an Old Puzzle
Elizabeth C. Smyth et al.
JAMA ONCOLOGY (2016)
Hemophagocytic lymphohistiocytosis caused by dominant-negative mutations in STXBP2 that inhibit SNARE-mediated membrane fusion
Waldo A. Spessott et al.
BLOOD (2015)
Synergistic antitumor interactions between MK-1775 and panobinostat in preclinical models of pancreatic cancer
Guan Wang et al.
CANCER LETTERS (2015)
Machine Learning in Medicine
Rahul C. Deo
CIRCULATION (2015)
Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival
Mariya Farooqui et al.
MOLECULAR CANCER (2015)
Combined newborn screening for familial hemophagocytic lymphohistiocytosis and severe T- and B-cell immunodeficiencies
Stephan Borte et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis
Haizhong Feng et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial
Thomas Thomaidis et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Transcriptional regulation of Munc13-4 expression in cytotoxic lymphocytes is disrupted by an intronic mutation associated with a primary immunodeficiency
Frank Cichocki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Human effector T cells derived from central memory cells rather than CD8+T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy
Fenglin Wu et al.
CANCER LETTERS (2013)
Adrenomedullin Blockade Suppresses Growth of Human Hormone-Independent Prostate Tumor Xenograft in Mice
Caroline Berenguer-Daize et al.
CLINICAL CANCER RESEARCH (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Adrenomedullin is Up-regulated in Patients With Pancreatic Cancer and Causes Insulin Resistance in β Cells and Mice
Gaurav Aggarwal et al.
GASTROENTEROLOGY (2012)
Adrenomedullin expression in epithelial ovarian cancers and promotes HO8910 cell migration associated with upregulating integrin α5β1 and phosphorylating FAK and paxillin
Boya Deng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D
Marie Meeths et al.
BLOOD (2011)
Tumor-Associated Macrophages Promote Angiogenesis and Melanoma Growth via Adrenomedullin in a Paracrine and Autocrine Manner
Peiwen Chen et al.
CLINICAL CANCER RESEARCH (2011)
Decreased Selenium-Binding Protein 1 in Esophageal Adenocarcinoma Results from Posttranscriptional and Epigenetic Regulation and Affects Chemosensitivity
Amy L. Silvers et al.
CLINICAL CANCER RESEARCH (2010)
Identification of novel neuroendocrine-specific tumour genes
E. Hofsli et al.
BRITISH JOURNAL OF CANCER (2008)
Tumor-node-metastasis staging of pancreatic adenocarcinoma
Matthew H. G. Katz et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Hypoxia-inducible adrenomedullin accelerates hepatocellular carcinoma cell growth
Su Cheol Park et al.
CANCER LETTERS (2008)
Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets
Yujin Hoshida et al.
PLOS ONE (2007)
Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR
Vijaya Ramachandran et al.
CANCER RESEARCH (2007)
Novel candidate tumour suppressor gene loci on chromosomes 11q23-24 and 22q13 involved in human insulinoma tumourigenesis
Y. M. H. Jonkers et al.
JOURNAL OF PATHOLOGY (2006)
CDCA4 is an E2F transcription factor family-induced nuclear factor that regulates E2F-dependent transcriptional activation and cell proliferation
Reiko Hayashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Validation of a postresection pancreatic adenocarcinorna nomogram for disease-specific survival
CR Ferrone et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Reduced selenium-binding protein I expression is associated with poor outcome in lung adenocarcinomas
GA Chen et al.
JOURNAL OF PATHOLOGY (2004)
Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth
MK Oehler et al.
ONCOGENE (2001)
Share Paper
